- Home
- ABUS vs LEGH Comparison
ABUS vs LEGH Comparison
Compare ABUS & LEGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- LEGH
- Stock Information
- Founded
- ABUS 2005
- LEGH 2005
- Country
- ABUS United States
- LEGH United States
- Employees
- ABUS N/A
- LEGH N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- LEGH Homebuilding
- Sector
- ABUS Health Care
- LEGH Consumer Discretionary
- Exchange
- ABUS Nasdaq
- LEGH Nasdaq
- Market Cap
- ABUS 611.0M
- LEGH 588.8M
- IPO Year
- ABUS N/A
- LEGH 2018
- Fundamental
- Price
- ABUS $3.37
- LEGH $26.74
- Analyst Decision
- ABUS Strong Buy
- LEGH Strong Buy
- Analyst Count
- ABUS 3
- LEGH 2
- Target Price
- ABUS $5.67
- LEGH $29.00
- AVG Volume (30 Days)
- ABUS 636.5K
- LEGH 60.9K
- Earning Date
- ABUS 08-06-2025
- LEGH 08-07-2025
- Dividend Yield
- ABUS N/A
- LEGH N/A
- EPS Growth
- ABUS N/A
- LEGH 2.38
- EPS
- ABUS N/A
- LEGH 2.23
- Revenue
- ABUS $15,416,000.00
- LEGH $184,284,000.00
- Revenue This Year
- ABUS $3.35
- LEGH N/A
- Revenue Next Year
- ABUS N/A
- LEGH $7.69
- P/E Ratio
- ABUS N/A
- LEGH $12.01
- Revenue Growth
- ABUS 53.23
- LEGH 8.79
- 52 Week Low
- ABUS $2.71
- LEGH $21.58
- 52 Week High
- ABUS $4.73
- LEGH $29.25
- Technical
- Relative Strength Index (RSI)
- ABUS 54.05
- LEGH 76.96
- Support Level
- ABUS $3.33
- LEGH $24.50
- Resistance Level
- ABUS $3.45
- LEGH $27.29
- Average True Range (ATR)
- ABUS 0.12
- LEGH 1.06
- MACD
- ABUS 0.01
- LEGH 0.44
- Stochastic Oscillator
- ABUS 36.21
- LEGH 85.71
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
About LEGH Legacy Housing Corporation (TX)
Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to its customers to facilitate the sale of homes.